L. De-lau and M. Breteler, Epidemiology of Parkinson's disease, The Lancet Neurology, vol.5, issue.6, pp.525-535, 2006.
DOI : 10.1016/S1474-4422(06)70471-9

M. Rodriguez-oroz, M. Jahanshahi, and P. Krack, Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms, The Lancet Neurology, vol.8, issue.12, pp.1128-1139, 2009.
DOI : 10.1016/S1474-4422(09)70293-5

A. Abbott, Levodopa: the story so far, Nature, vol.466, issue.7310, pp.6-7, 2010.
DOI : 10.1038/466S6a

R. Bell and B. Zlokovic, Neurovascular mechanisms and blood???brain barrier disorder in Alzheimer???s disease, Acta Neuropathologica, vol.6, issue.1, pp.103-113, 2009.
DOI : 10.1007/s00401-009-0522-3

C. Iadecola, The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia, Acta Neuropathologica, vol.57, issue.3, pp.287-296, 2010.
DOI : 10.1007/s00401-010-0718-6

M. Patel, C. Coutinho, and H. Emsley, Prevalence of radiological and clinical cerebrovascular disease in idiopathic Parkinson's disease, Clinical Neurology and Neurosurgery, vol.113, issue.10, pp.830-834, 2011.
DOI : 10.1016/j.clineuro.2011.05.014

W. Nanhoe-mahabier, K. De-laat, J. Visser, J. Zijlmans, F. De-leeuw et al., Parkinson disease and comorbid cerebrovascular disease, Nature Reviews Neurology, vol.255, issue.10, pp.533-541, 2009.
DOI : 10.1038/nrneurol.2009.136

M. Fernandez-seara, E. Mengual, and M. Vidorreta, Cortical hypoperfusion in Parkinson's disease assessed using arterial spin labeled perfusion MRI, NeuroImage, vol.59, issue.3, pp.2743-2750, 2012.
DOI : 10.1016/j.neuroimage.2011.10.033

J. Westin, H. Lindgren, and J. Gardi, Endothelial Proliferation and Increased Blood-Brain Barrier Permeability in the Basal Ganglia in a Rat Model of 3,4-Dihydroxyphenyl-L-Alanine-Induced Dyskinesia, Journal of Neuroscience, vol.26, issue.37, pp.9448-9461, 2006.
DOI : 10.1523/JNEUROSCI.0944-06.2006

J. Choi, Y. Chen, E. Hamel, and B. Jenkins, Brain hemodynamic changes mediated by dopamine receptors: Role of the cerebral microvasculature in dopamine-mediated neurovascular coupling, NeuroImage, vol.30, issue.3, pp.700-712, 2006.
DOI : 10.1016/j.neuroimage.2005.10.029

H. Lindgren, K. Ohlin, and M. Cenci, Differential Involvement of D1 and D2 Dopamine Receptors in L-DOPA-Induced Angiogenic Activity in a Rat Model of Parkinson's Disease, Neuropsychopharmacology, vol.279, issue.12, pp.2477-2488, 2009.
DOI : 10.1016/S0008-6363(00)00268-6

S. Kalra, D. Grosset, and H. Benamer, Differentiating vascular parkinsonism from idiopathic Parkinson's disease: A systematic review, Movement Disorders, vol.19, issue.2 suppl, pp.149-156, 2010.
DOI : 10.1002/mds.22937

L. Edvinsson and D. Krause, Perivascular nerves in brain vessels, Cerebral Blood Flow and Metabolism, 2002.

T. Gurevich, A. Gur, N. Bornstein, N. Giladi, and A. Korczyn, Cerebral vasomotor reactivity in Parkinson's disease, multiple system atrophy and pure autonomic failure, Journal of the Neurological Sciences, vol.243, issue.1-2, pp.57-60, 2006.
DOI : 10.1016/j.jns.2005.11.028

N. Vokatch, H. Grotzsch, B. Mermillod, P. Burkhard, and R. Sztajzel, Is cerebral autoregulation impaired in Parkinson's disease? A transcranial Doppler study, Journal of the Neurological Sciences, vol.254, issue.1-2, pp.49-53, 2007.
DOI : 10.1016/j.jns.2006.12.017

B. Zamani, M. Mehrabani, S. Fereshtehnejad, and M. Rohani, Evaluation of cerebral vasomotor reactivity in Parkinson's disease: Is there any association with orthostatic hypotension?, Clinical Neurology and Neurosurgery, vol.113, issue.5, pp.368-372, 2011.
DOI : 10.1016/j.clineuro.2010.12.014

A. Krainik and M. Functional, Brain Mapping: From Neural Basis of Cognition to Surgical Applications Vienna, pp.45-59

Z. Jiang, A. Krainik, and O. David, Impaired fMRI activation in patients with primary brain tumors, NeuroImage, vol.52, issue.2, pp.538-548, 2010.
DOI : 10.1016/j.neuroimage.2010.04.194
URL : https://hal.archives-ouvertes.fr/inserm-00497736

A. Krainik, M. Hund-georgiadis, S. Zysset, and D. Von-cramon, Regional Impairment of Cerebrovascular Reactivity and BOLD Signal in Adults After Stroke, Stroke, vol.36, issue.6, pp.1146-1152, 2005.
DOI : 10.1161/01.STR.0000166178.40973.a7
URL : https://hal.archives-ouvertes.fr/inserm-00391163

F. Hamzei, R. Knab, C. Weiller, and J. Rother, The influence of extra- and intracranial artery disease on the BOLD signal in FMRI, NeuroImage, vol.20, issue.2, pp.1393-1399, 2003.
DOI : 10.1016/S1053-8119(03)00384-7

J. Han, A. Abou-hamden, and D. Mandell, Impact of Extracranial-Intracranial Bypass on Cerebrovascular Reactivity and Clinical Outcome in Patients With Symptomatic Moyamoya Vasculopathy, Stroke, vol.42, issue.11, pp.3047-3054, 2011.
DOI : 10.1161/STROKEAHA.111.615955

S. Cantin, M. Villien, and O. Moreaud, Impaired cerebral vasoreactivity to CO2 in Alzheimer's disease using BOLD fMRI, NeuroImage, vol.58, issue.2, pp.579-587, 2011.
DOI : 10.1016/j.neuroimage.2011.06.070

U. Yezhuvath, J. Uh, and Y. Cheng, Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease, Neurobiology of Aging, vol.33, issue.1, pp.75-82, 2012.
DOI : 10.1016/j.neurobiolaging.2010.02.005

W. Gibb and A. Lees, The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease., Journal of Neurology, Neurosurgery & Psychiatry, vol.51, issue.6, pp.745-752, 1988.
DOI : 10.1136/jnnp.51.6.745

R. Oldfield, The assessment and analysis of handedness: The Edinburgh inventory, Neuropsychologia, vol.9, issue.1, pp.97-113, 1971.
DOI : 10.1016/0028-3932(71)90067-4

J. Zijlmans, S. Daniel, A. Hughes, T. Revesz, and A. Lees, Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis, Movement Disorders, vol.47, issue.Pt 1, pp.630-640, 2004.
DOI : 10.1002/mds.20083

D. Mandell, J. Han, and J. Poublanc, Mapping Cerebrovascular Reactivity Using Blood Oxygen Level-Dependent MRI in Patients With Arterial Steno-occlusive Disease: Comparison With Arterial Spin Labeling MRI, Stroke, vol.39, issue.7, pp.2021-2028, 2008.
DOI : 10.1161/STROKEAHA.107.506709

S. Hirano, K. Asanuma, and Y. Ma, Dissociation of Metabolic and Neurovascular Responses to Levodopa in the Treatment of Parkinson's Disease, Journal of Neuroscience, vol.28, issue.16, pp.4201-4209, 2008.
DOI : 10.1523/JNEUROSCI.0582-08.2008

E. Cohen, K. Ugurbil, and S. Kim, Effect of Basal Conditions on the Magnitude and Dynamics of the Blood Oxygenation Level???Dependent fMRI Response, Journal of Cerebral Blood Flow & Metabolism, vol.14, pp.1042-1053, 2002.
DOI : 10.1097/00004647-200209000-00002

B. Stefanovic, J. Warnking, K. Rylander, and G. Pike, The effect of global cerebral vasodilation on focal activation hemodynamics, NeuroImage, vol.30, issue.3, pp.726-734, 2006.
DOI : 10.1016/j.neuroimage.2005.10.038
URL : https://hal.archives-ouvertes.fr/inserm-00388982

C. Buhmann, V. Glauche, H. Sturenburg, M. Oechsner, C. Weiller et al., Pharmacologically modulated fMRI---cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients, Brain, vol.126, issue.2, pp.451-461, 2003.
DOI : 10.1093/brain/awg033

B. Haslinger, P. Erhard, and N. Kampfe, Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa, Brain, vol.124, issue.3, pp.558-570, 2001.
DOI : 10.1093/brain/124.3.558

B. Ng, S. Palmer, R. Abugharbieh, and M. Mckeown, Focusing effects of L-dopa in Parkinson's disease, Human Brain Mapping, vol.32, issue.Part 2, pp.88-97, 2010.
DOI : 10.1002/hbm.20847

A. Quattrone, M. Zappia, and U. Aguglia, The subacute levodopa test for evaluating long-duration response in parkinson's disease, Annals of Neurology, vol.66, issue.3, pp.389-395, 1995.
DOI : 10.1002/ana.410380308

F. Fera, G. Nicoletti, and A. Cerasa, Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease, Brain Research Bulletin, vol.74, issue.1-3, pp.75-83, 2007.
DOI : 10.1016/j.brainresbull.2007.05.009